Navigation Links
Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
Date:1/24/2011

er of 2009.  For the year, Sensipar / Mimpara sales increased 10 percent to $714 million versus $651 million in 2009.  These sales increases were driven principally by international demand.

Worldwide sales of Vectibix® (panitumumab) increased 20 percent to $79 million in the fourth quarter of 2010 as compared to $66 million in the fourth quarter of 2009.  For the year, worldwide Vectibix sales were $288 million in 2010 versus $233 million in 2009, a 24 percent increase.  These sales increases were driven principally by international demand.

Worldwide Nplate® (romiplostim) sales increased 59 percent to $65 million in the fourth quarter of 2010 versus $41 million in the fourth quarter of 2009.  For the year, worldwide Nplate sales increased 108 percent to $229 million in 2010 versus $110 million in 2009.  These sales increases were driven by an increase in worldwide demand.

Worldwide Prolia® (denosumab) sales in the fourth quarter and for the year were $20 million and $33 million, respectively, reflecting steady progress with physicians, patients and payers in the U.S. and internationally.

Following FDA approval of XGEVATM (denosumab) on Nov. 18, 2010, U.S. sales for the fourth quarter 2010 were $8 million.

Operating Expense Analysis on an Adjusted Basis:Cost of sales increased to 15.1 percent of sales for the fourth quarter of 2010 versus 14.3 percent of sales for the fourth quarter of 2009.  This increase was driven primarily by higher inventory write-offs due to the voluntary ENBREL recall and by higher bulk material cost, partially offset by lower excess capacity charges and lower royalties.For 2010, cost of sales increased to 15.0 percent of sales versus 14.5 percent of sales in 2009.  This increase was driven primarily by higher bulk material cost and higher inventory write-offs due to the voluntary EPOGEN, Procrit
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, ... on discovering, developing and commercializing novel therapeutics from ... closing of the previously announced offering on the ... Depositary Shares (ADSs) at a price of $112.00 ... million (before deducting underwriting discount, commissions and offering ...
(Date:5/5/2015)... 5, 2015 North American ophthalmology ... in 2014, and is estimated to grow to $138.3 ... 2014 to 2019. Browse through the TOC ... an analysis of industry trends and segments, with the ... http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html Early buyers will receive ...
(Date:5/5/2015)... the Netherlands , May 5, 2015 ... lower esophageal sphincter (LES) stimulation therapy for gastroesophageal ... and efficacy results. The results demonstrated an excellent ... regurgitation and the "gold-standard" esophageal acid exposure (measured ... of dependence on daily PPI medications. ...
Breaking Medicine Technology:GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3
... 3, 2010 , , , ... Artificial Sphincter (the AOS-C1000) to,Provide Bowel Control and Prevent Clinical Complications for People With,Stomas. , ... Stimatix GI, located in the Misgav Venture Accelerator, has reported,encouraging interim results in ... bowel,control. , , , ...
... May 3 Unisys Corporation announced today that it ... (HIM) business to Molina Healthcare, Inc. for $135 million ... , , ... business process outsourcing services to state governments for administering Medicaid and ...
Cached Medicine Technology:Stimatix GI Reports Encouraging Interim Results 2Unisys Completes Sale of Health Information Management Business 2
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... ( Optimity) will present at the ... 20 at 1:15 p.m. MT in Scottsdale, AZ. ... the nation’s leading nonprofit authority on the use ... information exchange. Donald Graf, National Director of Telemedicine ...
(Date:5/5/2015)... From the halls of Microsoft ... in enabling enterprise collaboration across platforms and devices, ... up and simplify the move to Microsoft Office ... for Office 365 enable organizations to migrate ... user adoption and effectively managing critical business data ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions last ... walkers participated in Global Lyme Alliance’s (GLA) inaugural “Lyme ... 5K and 10K runs and 1-and 3-mile walks were held ... for tick-borne disease research. The “Lyme Walk and Run” was ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance (TBDA), ...
(Date:5/5/2015)... QuickPick Travel ” was featured on NewsWatch as part of ... and large businesses making an impact in their industry. Susan ... the business review and shared with viewers how this is ... vacation for free. , Vacations are a sought-after opportunity to ... when people are preparing for vacations, they’re used to getting ...
(Date:5/5/2015)... Information Innovators Inc. (“Triple-i”), ... government, today announced its acquisition of Creative ... exclusively to federal government customers through its highly ... health services, and program management support. The company ... a Third Party Assessment Organization (3PAO) for cloud ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... 21 As a new year,approaches, the American Society ... 50 and over to add getting screened for,colorectal cancer ... Recent,studies have confirmed that a majority of Americans who ... is a preventable and,treatable disease when caught in its ...
... NEWPORT BEACH, Calif., Dec. 21 When men leave ... of care and,treatment. More often than not, a spouse ... often lacks the information and confidence,necessary to provide all ... being under more stress than the patient., Laurel ...
... December 21, 2007 The American Society ... role of endoscopy in treating dyspepsia, discomfort thought to ... of the population in Western countries. An upper ... evaluate the inside of the esophagus, stomach and small ...
... interferon almost doubled patients, time without disease progression, ... -- A combination treatment with two drugs, Avastin ... with kidney cancer, European researchers report. , "Based ... already considerable enthusiasm to use bevacizumab as a ...
... Warwick, Edinburgh, Dundee and the Czech Republics Institute of ... is up to 80 times more powerful than other ... to kill cancer cells in much more targeted ... as trans, trans, trans- [Pt(N3)2(OH)2(NH3)(py)], or a light ...
... focus On Software & Software Services Yields Two ... Genstar Capital, LLC, a middle,market private equity firm ... sciences, healthcare services, industrial technology, software and,software services, ... a,Managing Director., "We have been extremely pleased ...
Cached Medicine News:Health News:If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Year's Resolution 2Health News:If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Year's Resolution 3Health News:Helping Couples Fight Prostate Cancer, This Week on Your Cancer Today(TM) 2Health News:ASGE offers guidelines on endoscopic treatment of dyspepsia 2Health News:ASGE offers guidelines on endoscopic treatment of dyspepsia 3Health News:New Combo Treatment Extends Kidney Cancer Survival 2Health News:Light powered platinum more targeted and 80 times more powerful than similar cancer treatments 2Health News:Genstar Capital Appoints Mark Hanson to Managing Director 2
...
...
Headlight module is mounted on UltraLite Plus headband or sweatband....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
Medicine Products: